Enzolytics, Inc. (OTCMKTS:ENZC) Sees Large Decrease in Short Interest

Enzolytics, Inc. (OTCMKTS:ENZC) was the target of a large drop in short interest during the month of July. As of July 15th, there was short interest totalling 291,000 shares, a drop of 7.3% from the June 30th total of 314,000 shares. Based on an average daily volume of 13,091,500 shares, the days-to-cover ratio is currently 0.0 days.

Enzolytics Stock Performance

Shares of ENZC remained flat at $0.00 during trading hours on Wednesday. 19,107,362 shares of the stock traded hands, compared to its average volume of 11,176,248. Enzolytics has a 52 week low of $0.00 and a 52 week high of $0.06.

Enzolytics Company Profile

Enzolytics Inc, a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy.